Answers are grounded in this paper and cite their sources.
Most evidence about difficult-to-treat and severe asthma (DTTA) comes from clinical trials and registries. We aimed to identify people with DTTA from a large nationally representative asthma population and describe their characteristics and healthcare utilization compared with people whose asthma was not 'difficult-to-treat'.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: